Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary shares, no par value per share
-
Shares outstanding
-
2,006,543,493
-
Total 13F shares
-
132,491
-
Share change
-
+70,523
-
Total reported value
-
$75,781
-
Price per share
-
$0.5741
-
Number of holders
-
11
-
Value change
-
+$9,482
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) as of Q3 2025
As of 30 Sep 2025 PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 132,491 shares of stock of the company.
Largest 10 holders included Virtu Financial LLC, CITADEL ADVISORS LLC, GAMMA Investing LLC, BNP PARIBAS FINANCIAL MARKETS, MORGAN STANLEY, UBS Group AG, RHUMBLINE ADVISERS, Tradewinds Capital Management, LLC, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and SBI Securities Co., Ltd..
This table shows 11 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.